Clinical Trials Directory

Trials / Unknown

UnknownNCT03972631

Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
292 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Lifestyle intervention is the most important management of non-alcoholic fatty liver diseases (NAFLD) patients. Weight reductions of 5-10% can improve non-alcoholic steatosis and fibrosis. However, the options for treatment in the clinics are limited. Therefore, in this study, we investigated the effectiveness of different lifestyle intervention strategies in NAFLD patients.

Detailed description

This is a multicenter, randomized clinical trial nested within a cohort study in overweight and obese non-alcoholic fatty liver diseases (NAFLD) patients. In this study, 1500 eligible patients will be recruited, and demographic information and clinical data will be collected at baseline. Among these, 292 participants who agree to be randomized will be randomized into two intervention groups, including lifestyle education (LE), and intensive lifestyle intervention with low-carbohydrate diet (ILI), aiming to induce a loss ≥ 10% of initial weight in 3 months. The remainder will chose the treatment which they prefer according to the clinical practice. At the 3th, 6th and 12th month, all the participants will be followed, and data will be collected to study the development of NAFLD in different lifestyle intervention groups.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLifestyle educationLifestyle education include the diet principles, physical activity guideline and behavioral strategies.
BEHAVIORALIntensive lifestyle interventionOne to one intensive lifestyle intervention according to the diet and activity plan
BEHAVIORALHypocaloric low-carbohydrate diet planA diet plan with restricted calorie and carbohydrate intake

Timeline

Start date
2019-07-01
Primary completion
2020-04-01
Completion
2021-12-01
First posted
2019-06-03
Last updated
2019-06-13

Source: ClinicalTrials.gov record NCT03972631. Inclusion in this directory is not an endorsement.